Used primarily in pharmaceutical research as an intermediate in the synthesis of biologically active compounds. It serves as a building block for developing drugs targeting central nervous system disorders due to its structural similarity to known neuroactive agents. Its piperazine core and fluorinated aryl group enhance binding affinity to certain receptors, making it valuable in the design of serotonin and dopamine modulators. Also employed in the development of novel antidepressants, antipsychotics, and anxiolytic agents. Widely utilized in structure-activity relationship (SAR) studies to optimize pharmacokinetic and pharmacodynamic properties of new drug candidates.